The cyclotron operates under a Class II license issued to AHS by the Canadian Nuclear Safety Commission. The existing license has been extended for one year. A new license will be issue on June 1, 2023 and will be valid for 5 years. Communication with our community is a key part of our operation. AHS uses a public disclosure protocol to relate information to the public on the issues relevant to licensed activities in the facility including:
There are currently two AHS cyclotrons in Edmonton that produce radiopharmaceuticals for medical use located at: the Cross Cancer Institute and the Medical Isotope and Cyclotron Facility (MICF) at U of A South Campus. These cyclotrons are similar devices but can produce different radioisotopes, offering a more diverse suite of radiopharmaceuticals for medical diagnosis and research. The two cyclotrons in Edmonton have the ability to back each other up during shut-downs or maintenance.